Quantcast

Latest Factor VII Stories

2015-05-28 08:29:04

DUBLIN, May 26, 2015 /PRNewswire/ -- Research and Markets(http://www.researchandmarkets.com/research/htr7g8/2015_strategies)

2015-05-28 08:28:59

DUBLIN, May 26, 2015 /PRNewswire/ -- Research and Markets(http://www.researchandmarkets.com/research/9rp2x9/2015_strategies)

2015-05-27 16:28:29

DUBLIN, May 27, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5t4jwt/2015_strategies) has announced the addition of the "2015 Strategies

2015-05-21 16:30:45

MarketReportsOnline.com adds Global Hemophilia Market Report: 2015 Edition research report of 51 pages on the hemophilia industry to the pharmaceuticals intelligence collection of its research store.

2015-04-16 08:33:02

DEERFIELD, Ill., April 16, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner Baxter International Inc.

2015-04-16 08:32:31

Landmark Lightings and Community Activities Honor People Affected by the Disorder WESTON, Mass., April 16, 2015 /PRNewswire/ -- In recognition of World Hemophilia Day,

2015-03-30 08:32:07

rIX-FP Regulatory Submissions Now Made in EU and U.S.; Underscores CSL Behring's Legacy of Improving the Care for Patients with Bleeding Disorders KING OF PRUSSIA,

2015-03-26 12:30:04

PLAINSBORO, N.J., March 26, 2015 /PRNewswire/ -- Novo Nordisk today announced the company will launch Novoeight(®) (Antihemophilic Factor [Recombinant]) in the United States for people living

2015-02-11 08:33:15

DEERFIELD, Ill., Feb. 11, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner Baxter International Inc.

2015-02-04 12:26:50

CSL Behring Achieves Another Key Milestone in PROLONG-9FP, its Recombinant Factor IX Fusion Protein Development Program; Continues to Advance CSL Behring's Legacy of Improving Patient Well-Being


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'